NASDAQ:LIFE - aTyr Pharma Stock Price, Forecast & News

aTyr Pharma trades on the NASDAQ under the ticker symbol "LIFE."

aTyr Pharma's stock reverse split on Monday, July 1st 2019. The 1-14 reverse split was announced on Friday, June 28th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 28th 2019. An investor that had 100 shares of aTyr Pharma stock prior to the reverse split would have 7 shares after the split.

aTyr Pharma Inc (NASDAQ:LIFE) announced its quarterly earnings data on Thursday, November, 14th. The biotechnology company reported ($1.47) EPS for the quarter, missing the consensus estimate of ($1.43) by $0.04. The biotechnology company had revenue of $0.18 million for the quarter, compared to the consensus estimate of $0.06 million. View aTyr Pharma's Earnings History.

aTyr Pharma is scheduled to release their next quarterly earnings announcement on Monday, March 23rd 2020. View Earnings Estimates for aTyr Pharma.

3 equities research analysts have issued 1-year price targets for aTyr Pharma's stock. Their forecasts range from $4.00 to $8.00. On average, they anticipate aTyr Pharma's share price to reach $6.00 in the next twelve months. This suggests that the stock has a possible downside of 2.6%. View Analyst Price Targets for aTyr Pharma.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for aTyr Pharma in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for aTyr Pharma.

Media coverage about LIFE stock has been trending somewhat negative recently, according to InfoTrie. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. aTyr Pharma earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for aTyr Pharma.

aTyr Pharma saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 6,700 shares, an increase of 91.4% from the December 15th total of 3,500 shares. Based on an average daily trading volume, of 215,500 shares, the short-interest ratio is currently 0.0 days. Approximately 0.2% of the shares of the company are sold short. View aTyr Pharma's Current Options Chain.

Some companies that are related to aTyr Pharma include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), BIO-TECHNE (TECH), Bruker (BRKR), Charles River Laboratories Intl. (CRL), Cambrex (CBM), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM) and Harvard Bioscience (HBIO).

Based on aggregate information from My MarketBeat watchlists, some companies that other aTyr Pharma investors own include Wynn Resorts (WYNN), Biocept (BIOC), SCYNEXIS (SCYX), Viking Therapeutics (VKTX), Crispr Therapeutics (CRSP), Amicus Therapeutics (FOLD), QUALCOMM (QCOM), Rigel Pharmaceuticals (RIGL), Gilead Sciences (GILD) and Idera Pharmaceuticals (IDRA).

(LIFE) raised $76 million in an initial public offering on Thursday, May 7th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Citigroup served as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers.

Shares of LIFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LIFE stock can currently be purchased for approximately $6.16.

aTyr Pharma has a market capitalization of $23.96 million. The biotechnology company earns $-34,510,000.00 in net income (profit) each year or ($16.11) on an earnings per share basis. aTyr Pharma employs 42 workers across the globe.View Additional Information About aTyr Pharma.

The official website for aTyr Pharma is http://www.atyrpharma.com/.

aTyr Pharma's mailing address is 3545 JOHN HOPKINS COURT SUITE 250, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 858-731-8389 or via email at [email protected]